Dr. Albert Young transitions from CAO to SVP of Health Affairs at Astrana Health

Astrana Health, Inc.

Dr. Albert Young transitioned from CAO to SVP of Health Affairs effective April 23, 2024.
Compensation arrangements for Dr. Young remain unchanged following the transition.
No other officer changes or departures reported in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Dr. Albert Young

Senior Vice President of Health Affairs

ASTH · Astrana Health, Inc.

Effective: 2024-04-23
Filed: April 24, 2024, 7:59 PM ET

Effective April 23, 2024, Dr. Albert Young transitioned from his position as Chief Administrative Officer of Astrana Health, Inc. (the “Company”) to a new role as Senior Vice President of Health Affairs of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Albert Young changed role as Senior Vice President of Health Affairs at Astrana Health, Inc..

Action: transitioned
Role: Senior Vice President of Health Affairs

Exact text from the filing

Effective April 23, 2024, Dr. Albert Young transitioned from his position as Chief Administrative Officer of Astrana Health, Inc. (the “Company”) to a new role as Senior Vice President of Health Affairs of the Company.

View on SEC.gov

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-050759

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.